Benzensulfonamides bearing spyrohydantoin moieties act as potent inhibitors of human carbonic anhydrases II and VII and show neuropathic pain attenuating effects.
Angeli, A., Di Cesare Mannelli, L., Ghelardini, C., Peat, T.S., Bartolucci, G., Menicatti, M., Carta, F., Supuran, C.T.(2019) Eur J Med Chem 177: 188-197
- PubMed: 31136893 
- DOI: 10.1016/j.ejmech.2019.05.058
- Primary Citation of Related Structures:  
6ODZ, 6OE0, 6OE1 - PubMed Abstract: 
Carbonic Anhydrases have been recently validated as novel therapeutic targets in neuropathic pain. In this study, we combine the anticonvulsant propriety of spyrohydantoin and the CA inhibitor moiety of benzenesulfonamide to synthesize a novel series of spyrohydantoin bearing sulfonamides with strong activity against hCA II and VII ...